Lemaitre Vascular

LMAT

----

Current ValuationThe current P/E ratio is 27.59, below the reasonable range, cheaper than 99.39% of the time in the past 5 years, and the industry ranks 27/174, the industry Median -0.89.

27.59xP/E

Stock price$79.31Earnings per share$2.87

Historical Valuation

P/E ratioTypical rangeMedian

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.

012243648

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.

0x30x60x90x120x150x

P/E ratio
Name/Symbol
MDTUSMedtronic	20.91x	25.37%	$109.38B
SYKUSStryker	28.33x	52.92%	$105.64B
BSXUSBoston Scientific	16.40x	36.31%	$60.26B
RMDUSResmed	21.40x	11.53%	$32.60B
RYLPFUSKoninklijke Philips N.V.	17.75x	--	$22.96B
PHGUSKoninklijke Philips Elect	18.21x	14.78%	$23.55B
TRUMYUSTerumo	20.59x	--	$21.64B
STEUSSteris	25.40x	17.10%	$20.44B
ZBHUSZimmer Biomet	20.92x	37.01%	$16.88B
SNNUSSmith and Nephew	17.81x	42.74%	$11.31B
GMEDUSGlobus Medical Inc	18.49x	6.02%	$9.90B
PODDUSInsulet	24.83x	76.03%	$9.32B
SSMXYUSSysmex	28.56x	--	$7.22B
LIVNUSLivanova	22.19x	189.82%	$4.18B
TMDXUSTransMedics	18.53x	71.90%	$2.81B
LMATUSLemaitre Vascular	27.59x	13.99%	$1.81B
CNMDUSConmed	23.45x	156.95%	$1.32B
TCMDUSTactile	20.06x	36.59%	$498.80M
ELMDUSElectromed	20.68x	11.92%	$233.70M
BWAYUSBrainsway	24.11x	70.37%	$227.58M

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.